ALNOX.PA
Price:
$0.041
Market Cap:
$0
NOXXON Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. It is also developing NOX-E36, which has completed Phase 1/2 clinical trial for the treatment of diabetic nephropathy. The company has a collaboration agreement with Merck & Co. Inc. to study NOX-A12 combine...[Read more]
Industry
Biotechnology
IPO Date
2018-09-10
Stock Exchange
EURONEXT
Ticker
ALNOX.PA
According to NOXXON Pharma N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.19. This represents a change of -Infinity% compared to the average of 0 of the last 4 quarters.
The mean historical PE Ratio of NOXXON Pharma N.V. over the last ten years is -0.00. The current -0.19 PE Ratio has changed 1.98% with respect to the historical average. Over the past ten years (40 quarters), ALNOX.PA's PE Ratio was at its highest in in the December 2019 quarter at 0. The PE Ratio was at its lowest in in the December 2018 quarter at -0.01.
Average
-0.00
Median
-0.00
Minimum
-0.01
Maximum
-0.00
Discovering the peaks and valleys of NOXXON Pharma N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.40%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -83.85%
Minimum Annual PE Ratio = -0.01
Year | PE Ratio | Change |
---|---|---|
2021 | -0.00 | 3.90% |
2020 | -0.00 | -83.85% |
2019 | -0.01 | 3.40% |
2018 | -0.00 | -5.95% |
2017 | -0.00 | 111.25% |
2016 | -0.00 | 49.76% |
2015 | -0.00 | -14.31% |
The current PE Ratio of NOXXON Pharma N.V. (ALNOX.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.00
5-year avg
-0.00
10-year avg
-0.00
NOXXON Pharma N.V.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NOXXON Pharma N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NOXXON Pharma N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NOXXON Pharma N.V.'s PE Ratio?
How is the PE Ratio calculated for NOXXON Pharma N.V. (ALNOX.PA)?
What is the highest PE Ratio for NOXXON Pharma N.V. (ALNOX.PA)?
What is the 3-year average PE Ratio for NOXXON Pharma N.V. (ALNOX.PA)?
What is the 5-year average PE Ratio for NOXXON Pharma N.V. (ALNOX.PA)?
How does the current PE Ratio for NOXXON Pharma N.V. (ALNOX.PA) compare to its historical average?